Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia

European Respiratory Journal

Volumn 37, Issue 6, 2011, Pages 1332-1339

  Rello, J ^a   Ulldemolins, M ^a   Lisboa, T ^b   Koulenti, D ^c,p   Manez R ^d   Martin Loeches, I ^b,e   De Waele, J J ^f   Putensen, C ^g   Guven, M ^h   Deja, M ⁱ   Diaz, E ^b   Annane, D ^j   Amaya Villar, R ^k   Garnacho Montero, J ^k   Armaganidis, A ^c   Blot, S ^f   Brun Buisson, C ^l   Carneiro, A ^m   Dimopoulos, G ^c   Cardellino, S ⁿ   Komnos, A ^o   Krueger, W ^q,r   Macor, A ^s   Manno, E ^t   Marsh, B ^e   Martin, C ^u   Myrianthefs, P ^v   Nauwynck, M ^w   Papazian, L ^x   Wrigge, H ^g   Regnier, B ^y   Sole Violan, J ^z   Spina, G ^aa   Topeli, A ^ab   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h ERCIYES UNIVERSITY   (Turkey)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j RAYMOND POINCARÉ HOSPITAL   (France)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l Henri Mondor University Hospital   (France)

^m HOSPITAL DE SANTO ANTÓNIO   (Portugal)

ⁿ Ospedale Cardinal Massaia   (Italy)

^o GENERAL HOSPITAL OF LARISSA   (Greece)

^p UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^q UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^r Cardiology and Internal Intensive Medicine   (Germany)

^s AMEDEO DI SAVOIA HOSPITAL   (Italy)

^t MARIA VITTORIA HOSPITAL   (Italy)

^u HÔPITAL NORD   (France)

^v KAT HOSPITAL   (Greece)

^w General Hospital St Jan   (Belgium)

^x HÔPITAL SAINTE MARGUERITE   (France)

^y BICHAT HOSPITAL   (France)

^z Dr Negrin University Hospital   (Spain)

^aa MAURIZIANO HOSPITAL   (Italy)

^ab HACETTEPE UNIVERSITY   (Turkey)

more..

Author keywords

Antibiotic policy; Appropriate treatment; Combination therapy; Hospital acquired pneumonia; Ventilator associated pneumonia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; COLISTIN; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ACINETOBACTER; ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CHOICE; EUROPE; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; SURGICAL PATIENT; TREATMENT DURATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER INFECTIONS; ADULT; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLISTIN; CROSS INFECTION; EUROPE; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PIPERACILLIN; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; QUINOLONES; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79957987593     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00093010     Document Type: Article

References (20)

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903. (Pubitemid 34774654)
3. Sandiumenge A, Diaz E, Rodriguez A, et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother 2006; 57: 1197-1204. (Pubitemid 44644425)
4. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323-2329.
5. Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136: 1237-1248.
6. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033-1048.
7. Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 196-200. (Pubitemid 27293188)
8. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31: 2742-2751. (Pubitemid 38010630)
9. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-474. (Pubitemid 29083057)
10. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med 2003; 31: 2544-2551. (Pubitemid 37281742)
11. Rello J, Paiva JA, Baraibar J, et al. International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia. Chest 2001; 120: 955-970. (Pubitemid 32888237)
12. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129: 1210-1218.
13. Sandiumenge A, Diaz E, Bodi M, et al. Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy". Intensive Care Med 2003; 29: 876-883.
14. Hosmer D, Lemeshow S, eds. Applied Logistic Regression. 2nd Edn. New York, John Wiley and Sons Inc., 2003.
15. Koulenti D, Lisboa T, Brun-Buisson C, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009; 37: 2360-2368.
16. Vogelaers D, De Bels D, Foret F, et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates - a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents 2010; 35: 375-381.
17. Rello J, Ausina V, Castella J, et al. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest 1992; 102: 525-529.
18. Masterton R, Craven D, Rello J, et al. Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development. J Antimicrob Chemother 2007; 60: 206-213. (Pubitemid 47248426)
19. Bonten MJ, Gaillard CA, Johanson WG Jr, et al. Colonization in patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med 1994; 150: 1332-1340. (Pubitemid 24356649)
20. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596. (Pubitemid 43810035)